Evidence map›Paper›PMID 28348553›Full record

ArticleFrontiers in microbiology2017

Exploring the Antimicrobial and Antitumor Potentials of

Maged S Ahmad, Ahmed O El-Gendy, Rasha R Ahmed, Hossam M Hassan, Hussein M El-Kabbany, Ahmed G Merdash

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Aquatic-derived Streptomyces cavourensis BA1 as a promising source of antibacterial metabolites against multidrug-resistant gram-negative pathogens.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Investigation of anti-microbial and cytotoxic potential of Streptomyces werraensis GRS9 derived from the sediments of river Ganga.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  8. Article
  9. EditingEngineering in life sciences · 2024
    Article
  10. Article
  11. Evaluation of the Cytotoxicity of Secondary Bioactive Compounds Produced byInternational journal of molecular and cellular medicine · 2024
    Article
  12. Article
  13. Article
  14. Antifungal Mechanism of Metabolites from Newly IsolatedJournal of fungi (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Genomic analysis ofMolecular biology research communications · 2022
    Article
  19. Bioactive antifungal metabolites produced by Streptomyces amritsarensis V31 help to control diverse phytopathogenic fungi.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  20. 3 Biotech · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maged S AhmadBotany and Microbiology Department, Faculty of Science, Beni-Suef University Beni-Suef, Egypt.
Ahmed O El-GendyMicrobiology and Immunology Department, Faculty of Pharmacy, Beni-Suef University Beni-Suef, Egypt.
Rasha R AhmedZoology Department, Faculty of Science, Beni-Suef University Beni-Suef, Egypt.
Hossam M HassanPharmacognosy Department, Faculty of Pharmacy, Beni-Suef University Beni-Suef, Egypt.
Hussein M El-KabbanyHealth Research Department, The National Center for Radiation Research and Technology, Atomic Energy Authority Beni-Suef, Egypt.
Ahmed G MerdashBotany and Microbiology Department, Faculty of Science, Beni-Suef University Beni-Suef, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of extensive antibiotics resistant bacteria increased the demands for mining out new sources of antimicrobial agents. Actinomycetes, especially

Indexed as

actinomycetesantimicrobialantitumordiketopiperazineStreptomyces sp.Streptomyces vinaceusdrappus

Identifiers

PMID28348553
PMCPMC5346535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.